Top

Archives of Gynecology and Obstetrics

Published in:

01-05-2016 | Maternal-Fetal Medicine

Carbetocin versus oxytocin in the management of atonic post partum haemorrhage (PPH) after vaginal delivery: a randomised controlled trial

Authors: Ahmed Mohamed Maged, AbdelGany M. A. Hassan, Nesreen A. A. Shehata

Published in: Archives of Gynecology and Obstetrics | Issue 5/2016

Abstract

Objective

The objective of this study is to compare the effectiveness and safety of carbetocin vs. oxytocin in the management of atonic post partum haemorrhage (PPH) after vaginal delivery.

Methods

A prospective randomised study was conducted in which 100 pregnant women were randomised into 2 equal groups: group 1 received Carbetocin 100 µgm (Pabal^® Ferring, UK) and group 2 received oxytocin 5 IU (Syntocinon^®, Novartis, Switzerland).

Results

The amount of blood loss and the need for other uterotonics were significantly lower in the carbetocin group (811 ± 389.17 vs. 1010 ± 525.66 and 10/50 vs. 21/50). There was no significant difference between the carbetocin and oxytocin groups regarding occurrence of major PPH (6 vs. 11), the need for blood transfusion (6 vs. 9), the difference between blood haemoglobin levels before delivery and 24 h after delivery (0.6 ± 0.28 vs. 0.56 ± 0.25), respectively. There was no significant difference between the 2 study groups regarding both systolic and diastolic blood pressure measured immediately after the drug administration and at 30 and 60 min later. Regarding the drugs side effects, there was no significant difference between the 2 groups in the occurrence of nausea, vomiting, tachycardia, flushing, dizziness, headache, shivering, metallic taste, dyspnea, palpitations and itching.

Conclusions

Carbetocin is a better alternative to oxytocin in management of atonic PPH with non-significant hemodynamic changes or side effects .

Gülmezoglu AM, Souza JP, Chou D, Mathai M, Hill S, Abalos E (2009) WHO guidelines for the management of postpartum haemorrhage and retained placenta [Internet]. World Health Organization, Geneva, Switzerland

Canadian Perinatal Surveillance System (2013) Perinatal health indicators for Canada 2013: a report from the Canadian Perinatal Surveillance System [Internet]. Public Health Agency of Canada, Ottawa, Ontario

World Health Organization, United Nations Children’s Fund, United Nations Population Fund, World Bank (2012) Trends in maternal mortality: 1990–2010. WHO, UNICEF, UNFPA and The World Bank estimates. World Health Organization, Geneva

Callaghan WM, Kuklina EV, Berg CJ (2010) Trends in postpartum hemorrhage: United States, 1994–2006. Am J Obstet Gynecol 202(4):353CrossRefPubMed

Ford JB, Roberts CL, Simpson JM, Vaughan J, Cameron CA (2007) Increased postpartum hemorrhage rates in Australia. Int J Gynaecol Obstet 98(3):237–243CrossRefPubMed

Joseph KS, Rouleau J, Kramer MS, Young DC, Liston RM, Baskett TF (2007) Maternal Health Study Group of the Canadian Perinatal Surveillance System. Investigation of an increase in postpartum haemorrhage in Canada. BJOG 114(6):751–759CrossRefPubMed

Kramer MS, Berg C, Abenhaim H, Dahhou M, Rouleau J, Mehrabadi A, Joseph KS (2013) Incidence, risk factors, and temporal trends in severe postpartum hemorrhage. Am J Obstet Gynecol 209(5):449CrossRefPubMed

Mehrabadi A, Hutcheon JA, Lee L, Kramer MS, Liston RM, Joseph KS (2013) Epidemiological investigation of a temporal increase in atonic postpartum haemorrhage: a population-based retrospective cohort study. BJOG 120(7):853–862CrossRefPubMedPubMedCentral

Rossen J, Okland I, Nilsen OB, Eggebø TM (2010) Is there an increase of postpartum hemorrhage, and is severe hemorrhage associated with more frequent use of obstetric interventions? Acta Obstet Gynecol Scand 89(10):1248–1255CrossRefPubMed

10.

Smit M, Sindram SI, Woiski M, Middeldorp JM, Van roosmalen J (2013) The development of quality indicators for the prevention and management of postpartum haemorrhage in primary midwifery care in the Netherlands. BMC Pregnancy Childbirth 13:194CrossRefPubMedPubMedCentral

11.

Mehrabadi A, Hutcheon JA, Lee L, Liston RM, Joseph KS (2012). Trends in postpartum hemorrhage from 2000 to 2009: a population-based study. BMC Pregnancy Childbirth 12:108. doi:10.1186/1471-2393-12-108 CrossRefPubMedPubMedCentral

12.

Naef RW, Chauhan SP, Chevalier SP, Roberts WE, Meydrech EF, Morrison JC (1994) Prediction of hemorrhage at cesarean delivery. Obstet Gynecol 83(6):923–926CrossRefPubMed

13.

Knight M, Callaghan WM, Berg C, Alexander S, Bouvier-Colle MH, Ford JB, Joseph KS, Lewis G, Liston RM, Roberts CL, Oats J, Walker J (2009) Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the International Postpartum Hemorrhage Collaborative Group. BMC Pregnancy Childbirth 9:55CrossRefPubMedPubMedCentral

14.

Elbourne DR, Prendiville WJ, Carroli G, Wood J, Mcdonald S (2001) Prophylactic use of oxytocin in the third stage of labour. Cochrane Database Syst Rev 4:CD001808PubMed

15.

Su LL, Chong YS, Samuel M (2007) Oxytocin agonists for preventing postpartum haemorrhage. Cochrane Database Syst Rev 3:CD005457PubMed

16.

Wedisinghe L, Macleod M, Murphy DJ (2008) Use of oxytocin to prevent haemorrhage at caesarean section—a survey of practice in the United Kingdom. Eur J Obstet Gynecol Reprod Biol 137(1):27–30CrossRefPubMed

17.

Chard T, Boyd NR, Forsling ML, Mcneilly AS, Landon J (1970) The development of a radioimmunoassay for oxytocin: the extraction of oxytocin from plasma, and its measurement during parturition in human and goat blood. J Endocrinol 48(2):223–234CrossRefPubMed

18.

Liabsuetrakul T, Choobun T, Peeyananjarassri K, Islam QM (2007) Prophylactic use of ergot alkaloids in the third stage of labour. Cochrane Database Syst Rev 2:CD005456PubMed

19.

Hunter DJ, Schulz P, Wassenaar W (1992) Effect of carbetocin, a long-acting oxytocin analog on the postpartum uterus. Clin Pharmacol Ther 52(1):60–67CrossRefPubMed

20.

Attilakos G, Psaroudakis D, Ash J, Buchanan R, Winter C, Donald F, Hunt LP, Draycott T (2010) Carbetocin versus oxytocin for the prevention of postpartum haemorrhage following caesarean section: the results of a double-blind randomised trial. BJOG 117(8):929–936CrossRefPubMed

21.

Chong YS, Su LL, Arulkumaran S (2004) Current strategies for the prevention of postpartum haemorrhage in the third stage of labour. Curr Opin Obstet Gynecol 16(2):143–150CrossRefPubMed

22.

Samimi M, Imani-harsini A, Abedzadeh-kalahroudi M (2013) Carbetocin vs. syntometrine in prevention of postpartum hemorrhage: a double blind randomized control trial. Iran Red Crescent Med J 15(9):817–822CrossRefPubMedPubMedCentral

23.

Maged AM, Hassan AM, Shehata NA (2015) Carbetocin versus oxytocin for prevention of postpartum hemorrhage after vaginal delivery in high risk women. J Matern Fetal Neonatal Med 1–5

24.

Boucher M, Nimrod CA, Tawagi GF, Meeker TA, Rennicks White RE, Varin J (2004) Comparison of carbetocin and oxytocin for the prevention of postpartum hemorrhage following vaginal delivery:a double-blind randomized trial. J Obstet Gynaecol Can 26(5):481–488CrossRefPubMed

25.

Moertl MG, Friedrich S, Kraschl J, Wadsack C, Lang U, Schlembach D (2011) Haemodynamic effects of carbetocin and oxytocin given as intravenous bolus on women undergoing caesarean delivery: a randomised trial. BJOG 118(11):1349–1356CrossRefPubMed

Title: Carbetocin versus oxytocin in the management of atonic post partum haemorrhage (PPH) after vaginal delivery: a randomised controlled trial
Authors: Ahmed Mohamed Maged
AbdelGany M. A. Hassan
Nesreen A. A. Shehata
Publication date: 01-05-2016
Publisher: Springer Berlin Heidelberg
Published in: Archives of Gynecology and Obstetrics / Issue 5/2016
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-015-3911-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Carbetocin versus oxytocin in the management of atonic post partum haemorrhage (PPH) after vaginal delivery: a randomised controlled trial

Abstract

Objective

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objective

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 5/2016

Comparison of citalopram and venlafaxine’s role in treating sleep disturbances in menopausal women, a randomized, double-blind, placebo-controlled trial

p53 Arg72Pro polymorphism confers the susceptibility to endometriosis among Asian and Caucasian populations

Short-course postpartum (6-h) magnesium sulfate therapy in severe preeclampsia

Reply to: Bakri balloon vs. B-Lynch suture as hemostatic procedures for atonic bleeding: clarifications and concerns

Operative hysteroscopy for treatment of intrauterine pathologies does not interfere with later endometrial development in patients undergoing in vitro fertilization

The place of selective hysterosalpingography and tubal canalization among sub-fertile patients diagnosed with proximal tubal occlusion